Evidence that Systemic Gentamicin Suppresses Premature Stop Mutations in Patients with Cystic Fibrosis-Reference-Cited by-同舟云学术

Evidence that Systemic Gentamicin Suppresses Premature Stop Mutations in Patients with Cystic Fibrosis

Published:2001-06 Issue:7 Volume:163 Page:1683-1692
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

CLANCY J. P.,BEBÖK ZSUZSA,RUIZ FADEL,KING CHRIS,JONES JULIE,WALKER LYNN,GREER HEATHER,HONG JEONG,WING LISA,MACALUSO MAURIZIO,LYRENE RAYMOND,SORSCHER ERIC J.,BEDWELL DAVID M.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference32 articles.

1. Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA

2. Demonstration That CFTR Is a Chloride Channel by Alteration of Its Anion Selectivity

3. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)

4. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel

5. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressor tRNA in gene therapy;Science China Life Sciences;2024-06-24

2. Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons;Pharmaceuticals;2024-02-28

3. Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation;Journal of Cystic Fibrosis;2023-11

4. SCN1A as a therapeutic target for Dravet syndrome;Expert Opinion on Therapeutic Targets;2023-06-03

5. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis;Cochrane Database of Systematic Reviews;2023-03-03